Adicet Bio, Inc.
ACET
$0.6625
-$0.0085-1.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.74% | 4.03% | 6.43% | 6.21% | 3.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.61% | 1.08% | -5.85% | -7.36% | 0.00% |
| Operating Income | 2.61% | -1.08% | 5.85% | 7.36% | 0.00% |
| Income Before Tax | 2.58% | 38.90% | 7.72% | 9.28% | 1.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.58% | 38.90% | 7.72% | 9.28% | 1.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.58% | 38.90% | 7.72% | 9.28% | 1.29% |
| EBIT | 2.61% | -1.08% | 5.85% | 7.36% | 0.00% |
| EBITDA | 2.53% | -1.30% | 6.39% | 8.88% | 2.06% |
| EPS Basic | 53.85% | 71.09% | 56.26% | 50.72% | 4.48% |
| Normalized Basic EPS | 53.86% | 52.60% | 56.26% | 50.72% | 4.46% |
| EPS Diluted | 53.85% | 71.09% | 56.26% | 50.72% | 4.48% |
| Normalized Diluted EPS | 53.86% | 52.60% | 56.26% | 50.72% | 4.46% |
| Average Basic Shares Outstanding | 111.10% | 111.37% | 110.98% | 84.08% | 3.32% |
| Average Diluted Shares Outstanding | 111.10% | 111.37% | 110.98% | 84.08% | 3.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
